News stories from 2026
Consultant receives national recognition for leading pioneering type 1 diabetes research
Professor Parth Narendran, Honorary Consultant Physician at University Hospitals Birmingham, has been nationally recognised for his pioneering work in type 1 diabetes after receiving a prestigious Royal College of Physicians award.
AI-driven technology does not speed up lung cancer diagnosis
University Hospitals Birmingham (UHB) has contributed to a major national study exploring the use of artificial intelligence (AI) in diagnosing lung cancer.
QEHB physiotherapist selected for prestigious national research leadership programme
Congratulations to Caroline Miller, Clinical Specialist Physiotherapist, who has been selected to join Cohort 4 of the NIHR Senior Research Leader (SRL) Programme for nurses, midwives and allied health professionals (AHPs).
UHB clinicians contribute to breakthrough breast cancer research
Two University Hospitals Birmingham clinicians have played a key role in groundbreaking international research that could spare thousands of breast cancer patients from unnecessary chemotherapy.
Back on road after life-changing treatment
When Gareth Jones looks back on five years of treatment, he describes it as 'a pretty torrid time'. However, today, the 57-year-old is doing something he once wasn’t sure would ever be possible again - running marathons and enjoying life with his family.
Drug to delay Type 1 Diabetes approved for UK use
Diabetes experts in Birmingham have welcomed news that a drug that can delay the progression to insulin requiring type 1 diabetes in individuals with early-stage disease has been approved for use on the NHS, following an announcement by the National Institute for Health and Care Excellence (NICE).